Ben Zhou

Ben Zhou

Auto-generated profile, based on publicly available information

Ben Zhou

University of Pennsylvania

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Cell
Verified
Journal Article
Closed access
LWLianfeng Wu
Lianfeng Wu
BZBen Zhou
Ben Zhou
NONoriko Oshiro-Rapley
Noriko Oshiro-Rapley
MLMan Li
Man Li
JPJoao A. Paulo
Joao A. Paulo
ASAlexander A. Soukas
Alexander A. Soukas

1 April 2019 in Cell
Verified
Journal Article
Closed access
BZBen Zhou
Ben Zhou
JKJohannes Kreuzer
Johannes Kreuzer
CKCaroline Kumsta
Caroline Kumsta
LWLianfeng Wu
Lianfeng Wu
KKKimberli J. Kamer
Kimberli J. Kamer
ASAlexander A. Soukas
Alexander A. Soukas

4 April 2012 in Diabetologia
Verified
Journal Article
Open access
PDF file
BZB. Zhou
B. Zhou
CLC. Li
C. Li
WQW. Qi
W. Qi
YZY. Zhang
Y. Zhang
FZF. Zhang
F. Zhang
Qiwei ZhaiQiwei Zhai
Qiwei Zhai
Sirtuin-1 (SIRT1) is a potential therapeutic target to combat insulin resistance and type 2 diabetes. This study aims to identify a microRNA (miRNA) targeting SIRT1 to regulate hepatic insulin sensitivity.

18 January 2014 in Hepatology
Verified
Journal Article
Open access
PDF file
BZBen Zhou
Ben Zhou
YZYi Zhang
Yi Zhang
FZFang Zhang
Fang Zhang
YXYulei Xia
Yulei Xia
JLJun Liu
Jun Liu
Qiwei ZhaiQiwei Zhai
Qiwei Zhai
The protein deacetylase, sirtuin 1 (SIRT1), involved in regulating hepatic insulin sensitivity, shows circadian oscillation and regulates the circadian clock. Recent studies show that circadian misalignment leads to insulin resistance (IR); however, the underlying mechanisms are largely unknown. Here, we show that CLOCK and brain and muscle ARNT-like protein 1 (BMAL1), two core circadian transcription factors, are correlated with hepatic insulin sensitivity. Knockdown of CLOCK or BMAL1 induces hepatic IR, whereas their ectopic expression attenuates hepatic IR. Moreover, circadian change of insulin sensitivity is impaired in Clock mutant, liver-specific Bmal1 knockout (KO) or Sirt1 KO mice, and CLOCK and BMAL1 are required for hepatic circadian expression of SIRT1. Further studies show that CLOCK/BMAL1 binds to the SIRT1 promoter to enhance its expression and regulates hepatic insulin sensitivity by SIRT1. In addition, constant darkness-induced circadian misalignment in mice decreases hepatic BMAL1 and SIRT1 levels and induces IR, which can be dramatically reversed by resveratrol. Conclusion: These findings offer new insights for coordination of the circadian clock and metabolism in hepatocytes by circadian regulation of hepatic insulin sensitivity via CLOCK/BMAL1-dependent SIRT1 expression and provide a potential application of resveratrol for combating circadian misalignment-induced metabolic disorders. (Hepatology 2014;59:2196–2206)

14 May 2012 in Diabetes
Verified
Journal Article
Open access
YZYi Zhang
Yi Zhang
BZBen Zhou
Ben Zhou
FZFang Zhang
Fang Zhang
JWJingxia Wu
Jingxia Wu
YHYanan Hu
Yanan Hu
Qiwei ZhaiQiwei Zhai
Qiwei Zhai
Epidemiological studies indicate that patients with Alzheimer’s disease (AD) have an increased risk of developing type 2 diabetes mellitus (T2DM), and experimental studies suggest that AD exacerbates T2DM, but the underlying mechanism is still largely unknown. This study aims to investigate whether amyloid-β (Aβ), a key player in AD pathogenesis, contributes to the development of insulin resistance, as well as the underlying mechanism. We find that plasma Aβ40/42 levels are increased in patients with hyperglycemia. APPswe/PSEN1dE9 transgenic AD model mice with increased plasma Aβ40/42 levels show impaired glucose and insulin tolerance and hyperinsulinemia. Furthermore, Aβ impairs insulin signaling in mouse liver and cultured hepatocytes. Aβ can upregulate suppressors of cytokine signaling (SOCS)-1, a well-known insulin signaling inhibitor. Knockdown of SOCS-1 alleviates Aβ-induced impairment of insulin signaling. Moreover, JAK2/STAT3 is activated by Aβ, and inhibition of JAK2/STAT3 signaling attenuates Aβ-induced upregulation of SOCS-1 and insulin resistance in hepatocytes. Our results demonstrate that Aβ induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway and have implications toward resolving insulin resistance and T2DM.

13 February 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HWHaibin Wei
Haibin Wei
BZBen Zhou
Ben Zhou
FZFang Zhang
Fang Zhang
YTYanyang Tu
Yanyang Tu
YHYanan Hu
Yanan Hu
Qiwei ZhaiQiwei Zhai
Qiwei Zhai
Small non-coding RNAs constitute a large family of regulatory molecules with diverse functions. Notably, some small non-coding RNAs matched to rDNA have been identified as qiRNAs and small guide RNAs involved in various biological processes. However, a large number of small rDNA-derived RNAs (srRNAs) are usually neglected and yet to be investigated. We systematically investigated srRNAs using small RNA datasets generated by high-throughput sequencing, and found srRNAs are mainly mapped to rRNA coding regions in sense direction. The datasets from immunoprecipitation and high-throughput sequencing demonstrate that srRNAs are co-immunoprecipitated with Argonaute (AGO) proteins. Furthermore, the srRNA expression profile in mouse liver is affected by diabetes. Overexpression or inhibition of srRNAs in cultured cells shows that srRNAs are involved in various signaling pathways. This study presents a global view of srRNAs in total small RNA and AGO protein complex from different species, and demonstrates that srRNAs are correlated with diabetes, and involved in some biological processes. These findings provide new insights into srRNAs and their functions in various physiological and pathological processes.